These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 22613335)
1. [Proteomics-based identification of proapoptotic caspase adapter protein as a novel serum marker of non-small cell lung cancer]. Zhang H; Chen S; Huang L Zhongguo Fei Ai Za Zhi; 2012 May; 15(5):287-93. PubMed ID: 22613335 [TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of secreted proteins of non-small cell lung cancer. Huang LJ; Chen SX; Luo WJ; Jiang HH; Zhang PF; Yi H Ai Zheng; 2006 Nov; 25(11):1361-7. PubMed ID: 17094902 [TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase 1 is a promising biomarker for early detection of non-small cell lung cancer. Wang DB; Lu XK; Zhang X; Li ZG; Li CX Tumour Biol; 2016 Jan; 37(1):553-9. PubMed ID: 26232327 [TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of non-small cell lung cancer tissue interstitial fluids. Li S; Wang R; Zhang M; Wang L; Cheng S World J Surg Oncol; 2013 Aug; 11():173. PubMed ID: 23914992 [TBL] [Abstract][Full Text] [Related]
5. Systems biology analysis of the lung cancer‑related secretome. Feng L; Yang Y; Li M; Song J; Gao Y; Cheng S; Xiao T Oncol Rep; 2018 Aug; 40(2):1103-1118. PubMed ID: 29989649 [TBL] [Abstract][Full Text] [Related]
6. Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis. Tan F; Jiang Y; Sun N; Chen Z; Lv Y; Shao K; Li N; Qiu B; Gao Y; Li B; Tan X; Zhou F; Wang Z; Ding D; Wang J; Sun J; Hang J; Shi S; Feng X; He F; He J Mol Cell Proteomics; 2012 Feb; 11(2):M111.008821. PubMed ID: 22064513 [TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker. Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016 [TBL] [Abstract][Full Text] [Related]
8. [Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing non-small cell lung cancer patients from healthy people]. Yang SY; Xiao XY; Zhang WG; Sun XZ; Zhang LJ; Zhang W; Zhou B; Yang DC; He DC Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):31-4. PubMed ID: 16638298 [TBL] [Abstract][Full Text] [Related]
9. Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes. Jacot W; Lhermitte L; Dossat N; Pujol JL; Molinari N; Daurès JP; Maudelonde T; Mangé A; Solassol J J Thorac Oncol; 2008 Aug; 3(8):840-50. PubMed ID: 18670301 [TBL] [Abstract][Full Text] [Related]
10. Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker. Ayyub A; Saleem M; Fatima I; Tariq A; Hashmi N; Musharraf SG Int J Biochem Cell Biol; 2016 Jan; 70():68-75. PubMed ID: 26563422 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. Yildiz PB; Shyr Y; Rahman JS; Wardwell NR; Zimmerman LJ; Shakhtour B; Gray WH; Chen S; Li M; Roder H; Liebler DC; Bigbee WL; Siegfried JM; Weissfeld JL; Gonzalez AL; Ninan M; Johnson DH; Carbone DP; Caprioli RM; Massion PP J Thorac Oncol; 2007 Oct; 2(10):893-901. PubMed ID: 17909350 [TBL] [Abstract][Full Text] [Related]
12. Proteomics-based identification of tumor relevant proteins in lung adenocarcinoma. Zhou X; Xue L; Hao L; Liu S; Zhou F; Xiong H; Qi X; Lin D; Shao S Biomed Pharmacother; 2013 Sep; 67(7):621-7. PubMed ID: 23916545 [TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Xiao H; Zhang L; Zhou H; Lee JM; Garon EB; Wong DT Mol Cell Proteomics; 2012 Feb; 11(2):M111.012112. PubMed ID: 22096114 [TBL] [Abstract][Full Text] [Related]
14. ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer. Fan W; Yang H; Xue H; Sun Y; Zhang J Int J Clin Exp Pathol; 2015; 8(5):5503-8. PubMed ID: 26191257 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC). Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis. Howard BA; Wang MZ; Campa MJ; Corro C; Fitzgerald MC; Patz EF Proteomics; 2003 Sep; 3(9):1720-4. PubMed ID: 12973732 [TBL] [Abstract][Full Text] [Related]
17. Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer. Qu Y; Yang Y; Ma D; Xiao W Oncol Rep; 2012 Apr; 27(4):1277-83. PubMed ID: 22246423 [TBL] [Abstract][Full Text] [Related]
18. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer. Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383 [TBL] [Abstract][Full Text] [Related]
19. [Identification and clinical evaluation of lung cancer serum biomarker L-lactate dehydrogenase B]. Chen Y; Zhang H; Xu AJ; Liu JF; Li N; Wu SS; Huang LY; He DC; Xiao XY Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):577-81. PubMed ID: 17988549 [TBL] [Abstract][Full Text] [Related]
20. Reduced transthyretin expression in sera of lung cancer. Liu L; Liu J; Dai S; Wang X; Wu S; Wang J; Huang L; Xiao X; He D Cancer Sci; 2007 Oct; 98(10):1617-24. PubMed ID: 17683510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]